HLA-G and Endometrial Receptivity

Références bibliographiques

• Lessey B. Endometrial receptivity and the window of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000; 14: 775-788.
• Valdes CT, Schutt A, Simon C. Implantation failure of endometrial origin: it is not pathology, but our failure to synchronize the developing embryo with a receptive endometrium. Fertil Steril. 2017; 108: 15-18.
• Celik O, Acet M, Celik S, Sahin L, Koc O, et al. Hypothesis: Co-transfer of genuine embryos and implantation promoting compounds via artificial containers improve endometrium receptivity. Med Hypotheses. 2017; 103: 65-70.
• Edgell T, Evan J, Rombauts L, Vollenhoven B, Salamonsen L. Assessing Receptivity of the Human Endometrium to Improve Outcomes of Fertility Treatment. In: H Kanzaki, editor. Uterine Endometrial Function. Japan: Springer. 2016.
• Brar A, Frank G, Kessler C, Cedars M, Handwerger S. Progesterone-dependent decidualization of the human endometrium is mediated by cAMP. Endocrine. 1997; 6: 301- 307.
• Gellersen B, Brosens I, Brosens J. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med. 2007; 25: 445-453.
• Bergh PA, Navot D. The impact of embryonic development and endometrial maturity on the timing of implantation. Fertil Steril. 1992; 58: 537-542.
• Maity A, Williams A, Ryan L, Missmer S, Coull B, Hauser R. Analysis of in vitro fertilization data with multiple outcomes using discrete time-to-event analysis. Stat Med. 2014; 33: 1738-1749.
• Acosta A, Elberger L, Borghi M, Calamera JC, Papier S. Endometrial dating and determination of the implantation window in healthy fertile women. Fertil Steril. 2000; 73: 788-798.
• Mahajan N. Endometrial receptivity array: Clinical application. J Hum Reprod Sci. 2015; 8: 121–129.
• Zhang S, Lin H, Kong S, Wang S, R Armant. Physiological and molecular determinants of embryo implantation. Mol Aspects Med. 2013; 34: 939-980.
• Evans J, Hannan NJ, Edgell TA, Vollenhoven BJ, Lutjen PJ, et al. Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence. Hum Reprod Update. 2014; 20: 808–821.
• Casper RF. Yanushpolsky EH. Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support. Fertil Steril. 2016; 105: 867-872.
• Rashid N, Lalitkumar S, Lalitkumar P, Gemzell-Danielsson K. Endometrial receptivity and human embryo implantation. Am J Reprod Immunol. 2011; 66: 23-30.
• Navot D, Bergh PA, Williams M, Garrisi GJ, Guzman I, et al. An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab. 1991; 72: 408-413.
• Serafini P. Endometrial receptivity: evaluation criteria. Repro Biomedicine on line, 2010. Reproductive Bio Medicine Online (Reproductive Healthcare Limited). 2010; 21: S10- S10.
• Sharfi Y, Kharryasovna L, Dariko A, Mikhailovna E, Urievich I, et al. Endometrial receptivity evaluation in IVF cycles. Gynecol Endocrinol. 2015; 31: 74–78.
• American Society for Reproductive Medicine. A Practice Committee report: Optimal evaluation of the infertile female. ASRM. Fertil Steril. 2012; 98: 302–307.
• Cavagna M, Mantese JC. Biomarkers of endometrial receptivity – A review. Placenta. 2003; 24: S39–47.
• Chen G, Xin A, Liu Y, Shi C, Chen J, et al. Integrins β1 y β3 are biomarkers of uterine condition for embryo transfer. J Transl med. 2016; 14: 303.
• Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006; 6: 584-594.
• Meseguer M, Pellicer A, Simon C. MUC1 and endometrial receptivity. Mol Hum Reprod.1998; 4: 1089-1098.
• Ponnampalam A, Weston G, Trajstman A, Susil B, Rogers P. Molecular Human Reproduction. 2004; 10: 879–893.
• Díaz-Gimeno P, Horcajadas J, Martínez-Conejero J, Esteban F, Alama P, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011; 95: 50-60.
• Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, Gómez E, Fernández-Sánchez M, et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril. 2013; 100: 818-824.
• Vilella F, Moreno-Moya J, Balaguer N, Grasso A, Herrero M, et al. Hsa-miR-30d, secreted by the human endometrium is taken up by the pre-implantation embryo and might modify its transcriptome development 2015; 142: 3210-3221.
• Bjorkman, PJ, Saper, MA, Samraoui, B, Bennett, WS, Strominger, JL, et al. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987; 329: 506–512.
• Sipak-Szmigiel O, Ronin-Walknowska E, Cybulski C, Plonka T, Lubinski J. Antigens HLA-G, sHLA-G and sHLA-class I in reproductive failure. Folia Histochemica et Cytobiologica. 2007; 45: 137-141.
• Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur.J.Immunol. 2002; 32: 311-315.
• Noci I, Fuzzi B, Rizzo R, Melchiorri L, Criscuoli L, et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod. 2005; 20: 138-146.
• Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human embryos associated with higher pregnancy and implantation rates: assay of culture media using a new ELISA kit. Reproductive Bio Medicine Online. 2006; 13: 272-277. www.rbmonline.com/Article/2267 on web 5 June 2006.
• Roussev R, Coulam C. HLA-G and its role in implantation (review). J Assist Reprod Genet. 2007; 24: 288–295.
• Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends in Immunology. 2008; 29: 313–321.
• Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F, Choppin J, Dausset J, et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc. 2001; 33: 2355–2359.
• Wooding F, Burton G. Comparative placentation: Structures Functions and Evolution. Berlin: Springer. 2008.
• Meng F, Zapantis G, Williams SZ, Lieman HJ, Buyuk E, et al. Status of nucleolar channel systems in uterine secretions accurately reflect their prevalance - a marker for the window of implantation - in simultaneously obtained endometrial biopsies. Fertil Steril. 2018; 1: 165–671.
• Li J, Tan Z, Li M, Xia T, Liu P, Yu W. Proteomic analysis of endometrium in fertile women during the prereceptive and receptive phases after luteinizing hormone surge. Fertility and Sterility. 2011; 95: 1.
• Bissonnette L, Drissennek L, Antoine Y, Tiers L, Hirtz C, et al. Human S100A10 plays a crucial role in the acquisition of the endometrial receptivity phenotype. Cell Adh Migr. 2016; 10: 282–298.
• Braga D, Montanni D, Setti, A, Pilli G, Godoy A, et al. Uterine fluid lipidomic as an endometrial receptivity predictive tool. ASRM Abstracts. 2017; 108: 3.
• Vilella F, Ramírez L, Berlanga O, Martínez S, Alamá P, et al. PGE2 and PGF2α Concentrations in Human Endometrial Fluid as Biomarkers for Embryonic Implantation. J Clin Endocrinol Metab. 2013; 98: 4123– 4132.